No annual revenue total was found in Lumexa Imaging Holdings, Inc.'s SEC filings.
Lumexa Imaging Holdings, Inc. (LMRI) files with the SEC under industry code 8071, Services-Medical Laboratories. As of Jun 30, 2026 it held $69.7 million in cash and investments and $975.4 million in total debt.
Revenue
—
Net income
—
Operating cash flow
—
Free cash flow
—
EPS
—
Dividend per share
None
Shares outstanding
—
Net cash
$-905.65M
as of Jun 30, 2026
Operating margin
—
Company profile
- Industry
- Services-Medical Laboratories (SIC 8071)
- Listed as
- LMRI (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Raleigh, NC
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 2071288
Other Services-Medical Laboratories companies
- Natera, Inc. NTRA
- Labcorp Holdings Inc. LH
- Quest Diagnostics Inc DGX
- Guardant Health, Inc. GH
- Caris Life Sciences, Inc. CAI
- GRAIL, Inc. GRAL
- RadNet, Inc. RDNT
- BillionToOne, Inc. BLLN
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 12, 2026 | Aug 12, 2026 |
| 8-K |
Current report
Material agreement, New debt
|
Jun 30, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 12, 2026 | Jun 10, 2026 |
| 10-Q | Quarterly report | May 12, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 12, 2026 | May 12, 2026 |
All 71 Lumexa Imaging Holdings, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.